Erythematous scaly lesions on lower limbs prior to ixekizumab therapy (left), and after treatment with ixekizumab for one year (middle) and two years (right)

Erythematous scaly lesions on lower limbs prior to ixekizumab therapy (left), and after treatment with ixekizumab for one year (middle) and two years (right)

Figure 1. Erythematous scaly lesions on lower limbs prior to ixekizumab therapy (left), and after treatment with ixekizumab for one year (middle) and two years (right)

Erythematous scaly lesions on lower limbs prior to ixekizumab therapy (left), and after treatment with ixekizumab for one year (middle) and two years (right)